Spots Global Cancer Trial Database for Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma
Official Title: Multicenter Phase III, Randomized Study to Evaluate Treatment Customized According to RAP80 and BRCA1 Assessment in Patients With Advanced Non-small-cell Lung Cancer
Study ID: NCT00617656
Study Description
Brief Summary: Primary objective: · Progression free survival. Secondary objectives: * Assess Overall survival of both treatment groups. * Assess Tumor response rate using RECIST criteria * Assess Toxicity profile of patients enrolled in the study. * Exploratory evaluation of potential genetic markers of response or resistance to chemotherapy.
Detailed Description: Study population: Patients with advanced non-small-cell lung cancer who have not received treatment for the disease at this stage and who have a good performance status (ECOG 0-1) and measurable disease (at least one target lesion according to RECIST criteria). Duration of treatment: Six chemotherapy cycles will be given. The duration of every cycle will be 21 days. If the treatment is beneficial, it may be prolonged to a total of 8 cycles at the discretion of the investigator. Calendar and planned finalization date: The approximate duration of the study is 3 years of recruitment followed by 1 year of follow-up.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
H. Virgen de los Lirios, Alcoi, Alicante, Spain
H. Germans Trias i Pujol, Badalona, Barcelona, Spain
Hospital D'Althaia, Manresa, Barcelona, Spain
Hospital de Mataró, Mataró, Barcelona, Spain
Hospital de Cruces, Barakaldo, Bizkaia, Spain
Hospital Reina Sofía, Cordoba, Córdoba, Spain
F.H.Alcorcón, Alcorcon, Madrid, Spain
H. Severo Ochoa, Leganés, Madrid, Spain
Clinica Quiron, Pozuelo De Alarcón, Madrid, Spain
Hospital Universitario Quirón Madrid, Pozuelo De Alarcón, Madrid, Spain
Hospital de Basurto, Bilbao, Vizcaya, Spain
Hospital Ernest Lluch, Calatayud, Zaragoza, Spain
H. Juan Canalejo, A Coruña, , Spain
H. Santiago de Compostela, A Coruña, , Spain
H. Gral. Alicante, Alicante, , Spain
H. Torrecárdenas, Almería, , Spain
Hospital Torrecárdenas, Almería, , Spain
H. Clinic i Provincial, Barcelona, , Spain
H. Universitario Quirón Dexeus, Barcelona, , Spain
Hospital de La Santa Creu I Sant Pau, Barcelona, , Spain
H. Duran i Reynals-ICO, Barcelona, , Spain
Hospital del Mar, Barcelona, , Spain
Hospital General Yagüe, Burgos, , Spain
H. Provincial de Castellón, Castelló, , Spain
Hospital Universitari de Girona Dr. Josep Trueta, Girona, , Spain
Hospital Virgen de las Nieves, Granada, , Spain
Hospital Ciudad de Jaén, Jaén, , Spain
H. de la Princesa, Madrid, , Spain
H.U. Puerta de Hierro, Madrid, , Spain
Fundación Jiménez Díaz, Madrid, , Spain
Hospital Clínico San Carlos, Madrid, , Spain
Hospital Gregorio Marañon, Madrid, , Spain
Hospital Morales Messeguer, Murcia, , Spain
Hospital Carlos Haya, Málaga, , Spain
Hospital Virgen de la Victoria, Málaga, , Spain
Hospital Son Dureta/ Ses Espases, Palma De Mallorca, , Spain
H. Son Llátzer, Palma De Mallorca, , Spain
Hospital nuestra señora de Valme, Sevilla, , Spain
Hospital Clínico Universitario de Valencia, Valencia, , Spain
H. Gen. Univ. Valencia, Valencia, , Spain
Hospital Arnau de Vilanova, Valencia, , Spain
H. General de Vic, Vic, , Spain
Hospital Clínico Lozano Blesa, Zaragoza, , Spain
H. Clínico Lozano Blesa, Zaragoza, , Spain
Contact Details
Name: Rafel Rossell, MD
Affiliation: Principal Investigator of Fundación Grupo Español de Cáncer de Pulmón
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
